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Abstract 
Objectives: This study aimed to investigate the relationship between the presence of carotid 
arteriosclerosis (CAS) and blood pressure variability (BPV) in patients with essential 
hypertension. 
Methods: One hundred and forty four essential hypertension patients underwent ambulatory BP 
monitoring for 24 hours after hospitalization. Common BPV metrics were calculated. General 
clinical parameters, including age, gender, height, weight, history of coronary heart disease, stroke, 
diabetes, hypertension, smoking and drink, were recorded. Biochemical indices were obtained 
from a blood test. Carotid intima-media thickness (IMT) and carotid plaques were assessed to 
separate patients into a non-CAS group (IMT0.9 mm; n=82) and a CAS group (IMT>0.9 mm; 
n=62). BPV metrics and clinical parameters were analyzed and compared between the two groups. 
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Multivariate logistic regression analysis was performed to determine the associated risk factors of 
CAS. 
Results: Multivariate logistic regression analysis revealed that two BPV metrics, the standard 
deviation of daytime systolic blood pressure (SSD) (OR: 1.587, 95%CI: 1.242–2.028), the 
difference between average daytime SBP and nighttime SBP (OR: 0.914, 95%CI: 0.855-0.977), as 
well as three clinical parameters (age, OR: 1.098, 95%CI: 1.034-1.167; smoking, OR: 4.072, 
95%CI: 1.466–11.310, and fasting blood glucose, OR: 2.029, 95%CI: 1.407–2.928), were 
significant factors of CAS in essential hypertension patients. 
Conclusion: SSD, in combination with the ageing, smoking and FBG, has been identified as risk 
factors for CAS in patients with essential hypertension.  
Keywords: Hypertension, Carotid arteriosclerosis, Blood pressure variability (BPV), BP 
monitoring, Daytime SBP. 
1. Introduction 
Carotid atherosclerosis (CAS) is the pathological basis of cardiovascular and cerebrovascular 
diseases. Many clinical and physiological factors are significantly associated with CAS, including 
ageing, smoking, hypertension, diabetes. Among them, hypertension is one of the most closely 
related to CAS [1-2]. Published studies have confirmed that most patients with hypertension have 
different degrees of CAS [3-4].  
Patients with CAS normally have reduced blood pressure (BP) regulation because carotid sinus 
and aortic arch baroreflex play important roles in the regulation of cardiovascular reflex. The main 
clinical symptoms include either too high or too low BPs with large BP fluctuation, namely 
increased BPV. In general, patients with CAS have the carotid intima-media thickness (IMT) more 
than 0.9 [5-7]. Recent study has reported that daytime and all-day (24 h) systolic blood pressure 
variability (SBPV) in hypertensive patients are closely related to IMT [8], and SBPV is a good 
predictor of IMT progression. The clinical significance of BPV has become more attractive to 
researchers [9-11]. However, the relationship between different BPV metrics and CAS has not 
been fully agreed [8, 12], which requires further and comprehensive investigation. 
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Many studies have reported that BPV is a risk predictor for organ damage, and considered that 
BPV is more valuable than increased blood pressure (BP), leading to the suggestion that reducing 
BPV is more important than lowering BP [9-11,13-15]. Recent research has also suggested that 
BPV is higher in hypertensive patients  than in the healthy subjects [9-11]. Thus, controlling BPV 
has become a critical approach for BP management in hypertensive patients and patients with 
atherosclerotic diseases. 
BPV has been defined in different ways depending on the time duration, including: very 
short-term (beat-to-beat), short-term (minute-to-minute or reading-to-reading within a 24-h 
period), middle-term (day-to-day), long-term (visit-to-visit and seasonal) [9-11], from which 
different BPV metrics have been derived, including the standard deviations (SD) of systolic BP 
(SBP), diastolic BP(DBP) and pulse pressure (PP), as well as the variability uncorrelated with 
mean BP [9-11]. In addition, most studies mainly focused on the increased BPV while ignoring the 
clinical significance of decreased BPV. Most of current BPV metrics are consistent, and have 
positive correlation with target organ damage. However, some studies suggested that low-reactive 
BPV (such as blunted surge, nocturnal hypertension, orthostatic hypotension) is also a risk factor 
of cardiovascular disease, which is also associated with target organ lesions of hypertensive 
patients. Therefore, it is necessary to study hyporeactive BPV indices and explore its relationship 
with hypertensive atherosclerosis [16-17].   
Various factors, including neuroendocrine factors, vascular wall elasticity, environmental factors, 
emotional turmoil and sudden movements, affect BPV values [9-11]. Although many studies have 
provided evidence that CAS is closely associated with BPV [13-15,18], the relationship between 
CAS and BPV has not been quantified. In addition, different studies have used different BPV 
indices. This study aimed to explore the relationship between BPV metrics and the degree of CAS 
in patients with essential hypertension. 
2. Methods 
2.1 Patients 
The study recruited 144 essential hypertension patients who were hospitalized in the Department 
of Neurology and Department of Cardiology, Weihai Central Hospital Affiliated to Qingdao 
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University Medical College. There were 80 male and 64 female. Their age range was 45-89 year 
(66±9 year). This study was approved by the College Ethics Committee of Weihai Central 
Hospital Affiliated to Qingdao University Medical College. 
The diagnosis of essential hypertension was based on the criteria reported in the literature [14]. 
Specifically, all patients underwent manual BP measurements more than three times on three 
different days. Fifty five patients without receiving any antihypertensive drug treatment whose 
average SBP was over 140mmHg and/or a DBP over 90 mmHg were diagnosed as essential 
hypertension. Ninety patients with a history of hypertension who were taking antihypertensive 
drug treatment and had SBP lower than 140/90 mmHg were also considered as essential 
hypertension and included in the study.  
The exclusion criteria included: secondary hypertension, younger than 18 years, BP values higher 
than 220/110 mmHg without taking antihypertensive drugs. Patients who had any of the following 
conditions were also excluded: acute cerebrovascular disease; severe heart disease, acute heart 
failure, severe arrhythmias, severe valvular heart disease, recent or just occurred myocardial 
infarction, cirrhosis of the liver and severe kidney dysfunction, a variety of acute and chronic 
nephritis, nephrotic syndrome, acute and chronic renal failure, various acute and chronic 
infectious diseases, a variety of autoimmune diseases, hyperthyroidism, pregnancy, malignant 
tumors, serious hematological diseases and recent trauma and surgery. 
2.2 Clinical parameters  
Clinical parameters, including age, gender, height, and weight, were recorded, as well as the 
history of coronary heart disease, stroke, diabetes, hypertension, smoking and drink. Blood test 
was taken to measure the levels of triglyceride (TG), total cholesterol(TC), low-density lipoprotein 
cholesterol (LDL), high-density lipoprotein cholesterol (HDL), fasting blood glucose (FBG), uric 
acid, high-sensitivity C-reactive protein(hs-CRP), homocysteine (HCY), glomerular filtration rate 
(GFR), fibrinogen and urine protein. 
2.3 CAS diagnosis 
The Aplio 80color Doppler ultrasound device (Toshiba, Japan) with a 10 MHz probe was used to 
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determine the presence of CAS by an experienced clinical staff. Bilateral intima-media thickness 
(IMT) of the carotid artery vessel wall was measured. The larger bilateral IMT value was used to 
divide the patients into a non-CAS group (IMT0.9 mm; n=82) and a CAS group (IMT>0.9 mm; 
n=62). 
2.4 Ambulatory BP monitoring  
All the patients were asked to cease taking any antihypertensive drugs after hospitalization. Three 
to five days later, a standard 24-h ambulatory BP monitoring was performed for each patient for 
24 hours, from which the clinically reliable BP in the absence of medication was obtained. In all 
cases, the non-dominant upper arm of the patient was used in the BP measurement. While the cuff 
was inflated and deflated, the patient was advised to keep his/her arm relaxed and avoid 
movement. The BP measurement interval was 30 min during the daytime (6:00–22:00), and the 
nighttime (22:00-6:00) interval was 1h. The measurement successful rate threshold of 85% was 
used to determine whether a repeat measurement should be taken on alternative days. 
During the hospitalization, the patients were asked to undertake normal activities, but to avoid 
strenuous exercise and anything that might cause adverse mood swings. They were also advised to 
avoid alcohol, coffee, and tea during the 24h BP measurement period. Based on the recorded BP 
values from each patient, the BPV metrics were calculated, including the SD of 24 h SBP, SD of 
24 h DBP, SD of daytime SBP, SD of daytime DBP, SD of night SBP, SD of night DBP, the 
difference between daytime SBP and nighttime SBP (dSBP) and the difference between daytime 
DBP and nighttime DBP (dDBP). 
The percentage of patients with BP circadian rhythm was calculated, which was defined as the 
nocturnal BP decreases by 10%-20%. In addition, the percentage of patients with morning BP 
surge (MBPS) was also calculated, which was verified if the BP within 2 hours after arousal was 
more than 35 mmHg to the nocturnal BP. 
2.5 Statistical analysis 
The data were analyzed using the SPSS19.0 software (Armonk, NY: IBM Corp.). Measurement 
data that conformed to a normal distribution were presented as the mean ± SD, and comparisons 
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between the two groups (non-CAS and CAS groups) were performed using an independent sample 
t-test. Measurement data that did not conform to a normal distribution were presented using the 
median (interquartile range), with the group comparisons analyzed using the Mann–Whitney 
rank-sum test. The count data are presented as percentages (%), and the group comparisons were 
made using 
2 
tests or Fisher’s exact test. Independent variables with p-values lower than 0.1 in 
the single-factor analysis were employed in the multivariate logistic regression analysis to 
determine the risk factors for CAS. A P <0.05 was regarded as statistically significant. 
3. Results 
As shown in Table 1,there was no significant difference between the non-CAS and CAS groups in 
gender; history of drinking, hypertension and coronary heart disease; BMI values; levels of TC, 
HDL-C, LDL-C, uric acid; GFR and fibrinogen (all P>0.05). However, there was a significant 
difference between the two groups in age, history of smoking, history of stroke, history of diabetes 
and the levels of TG, FBG, hs-CRP, HCY and urine protein (P<0.01 or 0.05). 
Table 1.Comparison of the baseline demographics and clinical characteristics of the control group 
and carotid atherosclerosis (CAS) group. 
Parameters Control CAS P-value 
Demographic    
Patients number 82 62 -- 
Age, year 62.35±8.20 71.02±8.80 <0.01 
Male sex 44 (54%) 29 (47%) 0.345 
BMI, kgm-2 25.70±3.12 25.84±3.62 0.689 
Medical history 
   
Coronary heart disease 16 (17%) 15 (24%) 0.245 
Stroke 8 (10%) 15(24%) <0.05 
Diabetes 14 (17%) 24(39%) <0.01 
Hypertension 55 (79%) 53(85%) 0.301 
Smoking 21 (26%) 26 (42%) <0.05 
Drink 17 (21%) 14 (23%) 0.558 
Blood and Urine test 
   
TG, mmol/L 1.36 (0.99-1.98) 2.05 (1.11-2.76) <0.01 
TC, mmol/L 4.98 (4.27-5.54) 5.10 (4.31-5.72) 0.373 
LDL, mmol/L 3.08 (2.61-3.55) 3.28 (2.68-3.78) 0.221 
HDL, mmol/L 1.29 (1.08-1.46) 1.21 (1.08-1.34) 0.120 
FBG, mmol/L 5.88±1.21 7.60±1.99 <0.01 
Uric acid, umol/L 325.13±82.96 355.73±99.77 0.053 
hs-CRP, mg/L 1.55 (0.88-3.36) 3.45 (1.48-4.93) <0.01 
HCY, mmol/L 11.85 (10.00-15.88) 16.30 (11.1-22.93) <0.01 
GFR,ml/min 82.98±16.38 80.32± 16.02 0.343 
Fibrinogen, g/L 2.76±0.67 2.78±0.55 0.819 
Urine protein 12 (15%) 21(34%) <0.01 
Note: Data presented as number (%) or median (first and third quartiles) or mean ± SD (for these 
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with normal distribution). BMI: body mass index, TG: triglyceride, TC: total cholesterol, LDL: 
low-density lipoprotein, HDL: high-density lipoprotein, FBG: fasting blood glucose, hs-CRP: 
high-sensitivity C-reactive protein, HCY: homocysteine, GFR: glomerular filtration rate. 
Table 2 shows the 24h ambulatory BPV metrics from both the non-CAS and CAS groups. There 
were significant differences between the two groups in the average daytime SBP, night SBP, 24h 
SBP, daytime SSD, daytime DSD, 24h SSD, 24h DSD, 24h dSBP and the percentage of patients 
with BP circadian rhythm (all p<0.05). 
Table 2.Comparison of theblood pressure variability (BPV) data of the control group and carotid 
atherosclerosis (CAS) group. 
Metrics Control CAS P-value 
SBP    
SBP in daytime, mmHg 151.41±9.10 154.60±9.43 <0.05 
SBP in night, mmHg 132.56±10.91 140.68±9.48 <0.01 
SBP in 24 h, mmHg 142.48±8.64 147.66±8.26 <0.01 
SSD in daytime, mmHg 12.11±2.10 14.63±2.71 <0.01 
SSD in night, mmHg 9.40±1.70 10.03±2.06 0.050 
SSD in 24 h, mmHg 12.73±2.13 15.53±2.91 <0.01 
dSBP in 24 h, mmHg 16 (13-27) 14 (12-16.25) <0.05 
DBP 
   
DBP in daytime, mmHg 87.00±5.37 88.44±5.89 0.135 
DBP in night, mmHg 78.59±6.48 80.61±5.35 0.124 
DBP in 24 h, mmHg 82.74±5.47 84.45±5.07 0.102 
DSD in daytime, mmHg 8.89±1.97 10.05±2.29 <0.01 
DSD in night, mmHg 6.77±2.22 7.23±1.83 0.178 
DSD in 24 h, mmHg 9.72±1.93. 11.33±2.60 <0.01 
dDBP in 24 h, mmHg 8 (6.75-10） 8 (7-10） 0.905 
    
BP circadian rhythm 32(39%) 11 (18%) <0.05 
MBPS 21 (26%) 23 (37%) 0.126 
Note: Data presented as number (%) or median (first and third quartiles) or mean ± SD (for these 
with normal distribution). SBP: systolic blood pressure, SSD: standard deviation of SBP, DBP: 
diastolic blood pressure, DSD: standard deviation of DBP, dSBP: difference between daytime SBP 
and nighttime SBP, dDBP: difference between daytime DBP and nighttime DBP, MBPS: morning 
blood pressure surge. 
Table 3 shows the results from the multivariate logistic regression analysis, demonstrating that age, 
smoking history, FBG, and daytime SSD were significant risk factors for the appearance of CAS 
in patients with essential hyperetnsion (P<0.01 or 0.05). In addition, dSBP was a protect factor. 
Table 3.Results of multivariate logistic regression analysis for determining the risk factors for 












Age  0.094 0.031 9.3122 0.002 1.098 1.034-1.167 
Smoking 1.406 0.521 7.255 0.007 4.072 1.466-11.310 
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FBG 0.708 0.187 14.329 0.000 2.029 1.407-2.928 
SSD in daytime 0.462 0.125 13.604 0.000 1.587 1.242-2.028 
dSBP in 24 h -0.090 0.034 7.057 0.008 0.914 0.855-0.977 
Note: SEM: structural equation model, OR = odds ratio, CI = confidence interval, FBG: fasting 
blood glucose, SSD: standard deviation of SBP, dSBP: difference between daytime SBP and 
nighttime SBP. 
4. Discussion 
BPV has recently attracted great attention in basic and clinical research. An increasing number of 
studies have concluded that increased BPV, independent of the average BP values, is a risk factor 
for cardiovascular and cerebrovascular diseases, which is more valuable than average BP to 
predict target organ lesions in hypertensive patients [9-10]. However, other studies reported that 
BPV was not relevant to target organ damage in hypertensive patients [18, 19]. Therefore, further 
investigation on the role of BPV in cardiovascular and cerebrovascular diseases and target organ 
damage is of great significance. 
It has been widely accepted that hypertension is a risk factor for cardiovascular diseases, and BP is 
independently associated with AS. High BP elevates flow shear stress, causing severe damage to 
artery walls and leading to arterial intimal thickening, plaque formation, and plaque instability. 
Based on 24h ambulatory BP measurements, several studies have reported that both visit-to-visit 
BPV and short-term BPV were correlated with AS [10-11,13-15]. BPV has been reported to be 
closely associated with CAS [13-15, 20]. However, due to the existence of various BPV indices 
and poor reproducibility of these indices, it is difficult to draw solid conclusions about the 
relationship between BPV and CAS. García et al. reported that there was a correlation between 
IMT and the SD of the DBP in awake time after adjustment [21]. However, Mancia et al. reported 
that the association between 24h BPV (parameters of CV and SD) and carotid IMT disappeared 
after adjustment for confounding factors [22]. 
Various short-term BPV-related metrics, such as 24h SSD and 24h DSD, can be detected using 
24h ambulatory BP monitoring measurement. This method has been commonly used to clarify the 
relationship between BPV indices and BP, target organ damage, or other risk factors for 
cardiovascular disease [9-11]. However, there is no consensus on the normal range of the SD and 
coefficient of variation of BP in specific populations, as well as on how the BPV index changes in 
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hypertension patients with different degrees of target organ damage.  
In the current study, the univariate analysis revealed that the average daytime SBP, night SBP and 
daytime SSD, daytime DSD, 24h SSD, and 24h DSD in essential hypertension patients with CAS 
were higher than those with normal IMT. With a further multivariate logistic regression analysis, 
only the daytime SSD was shown to be independently associated with CAS in essential 
hypertension patients. This was in agreement with a study by Tatascioreet et al. [13], where it 
showed that the IMT progressively increased daytime SSD for hypertensive population, and that 
the daytime SSD was an independent predictor of IMT in hypertensive subjects. 
Our study also showed that dSBP was a protect factor for CAS in hypertensive patients. Previous 
studies have reported that the majority of BPV indices, including the pulse pressure, coefficient of 
variation independent of mean BP, 24-hour maximum and minimum BP difference, were all 
positively correlated with the BP level and the severity of target organ damage [11]. Our results 
suggested that the decrease of dSBP may be acted as a new indicator for target organ damage. The 
possible reason is that, with the carotid baroreflex regulation of reflex function decreasing, the 
average nighttime BP levels increases, leading to a smaller dSBP.  
The study demonstrated that age, smoking and FPF were positively correlated with CAS, which 
was consistent with some of the relevant literatures [23-25]. As mentioned above, there is no 
uniform standard of the normal SD or coefficient of variation of BP obtained from 24h ambulatory 
BP monitoring in different populations. Bilo et al. [26] analyzed 24h ambulatory BP monitoring 
data on 3,863 Italian and Polish patients and found that the 24h SSD and 24h DSD were 13.8±3.7 
and 10.7±2.5 mmHg, respectively. Tatasciore et al. [13] analyzed 24h ambulatory BP monitoring 
data on 180 hypertensive patients and reported the corresponding values of 13.0±4.1 and 10.9±4.0 
mmHg, respectively. Another study from Tatasciore’s group reported that the daytime SSD from 
patients with newly diagnosed hypertension was 12.9±4.1 mmHg, whereas it was 10.8±3.8mmHg 
for daytime DSD [27]. The findings of the present study were consistent with those of the 
aforementioned studies. As the sample size of patients, geographical difference, and times of BP 
measurement may affect the BPV results, it is difficult to unify the results. Future large-scale, 
multicenter studies are needed to explore the influence of different levels of BP on the degree of 
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target organ damage. 
Due to the relatively small sample size in the present study, selection bias is inevitable, making it 
difficult to draw any definitive conclusion. Nevertheless, this research is of clinical significance 
because it suggested that: 1) BPV had the potential to become a prospective evaluation index for 
CAS in hypertensive patients; 2) both the increase and decrease of BPV are likely to be abnormal.  
In the future, there is a need to study more indicators to explore the relationship between the 
reduction of BPV and target organ damage. To treat hypertension, prevent the progression of 
atherosclerosis, and reduce the risk of damage to various target organs, it is reasonable to focus on 
reducing both BPV and average BP values rather than only on reducing average BP values. Future 
studies are also needed to explore the use of BPV as an alternative indicator for atherosclerotic 
disease, cardiovascular disease, and all-cause mortality. Therefore, during the treatment of 
hypertension, especially for hypertensive patients with CAS, the impact of antihypertensive drugs 
on BPV should be concerned. For instance, calcium channel blockers, thiazide diuretics can 
improve BPV at different levels. The effect of angiotensin converting enzyme inhibitors, 
angiotensin receptor blockers on BPV is inconsistent, and β-blockers could increase BPV [28-31]. 
The latest guidelines from the European Society of Hypertension (2013) and National Institute for 
Health Care and Excellence (2013) acknowledge the importance of BPV in hypertension [32]. 
However, BPV has not been included in the diagnostic criteria and risk stratification of 
hypertension, and the guidelines for the management of hypertension have largely ignored the role 
of BPV during the selection of antihypertensive therapy [33]. Investigating the significance of 
BPV in individualized treatment in hypertensive patients is therefore a key point in future research. 
To achieve that, the relationship between BPV and complications of hypertension (such as CAS) 
should be scientifically explored.  
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Highlights 
 Relationship between the CAS and BPV in hypertension patients was studied. 
 SSD and the difference between daytime and nighttime SBP were BPV risk factors. 
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 Age, smoking and fasting blood glucose were identified as clinical risk factors. 
